Publications by authors named "Frank Bepperling"

Claim this Profile
P
Pharmacokinetics and safety of 6 % hydroxyethyl starch 130/0.4 in healthy male volunteers of Japanese ethnicity after single infusion of 500 ml solution.
Michiaki Yamakage, Frank Bepperling, Manfred Wargenau, Hideki Miyao

J Anesth· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
Sweeta D Gandhi, Richard B Weiskopf, Cornelius Jungheinrich, Robert Koorn, Diane Miller, Frank Bepperling

Anesthesiology· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients.
Eckart Klemm, Frank Bepperling, Martin A Burschka, Ralph Mösges,

Otol Neurotol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study.
Ralph Woessner, Markus T Grauer, Hans-Jürgen Dieterich, Frank Bepperling, Daniela Baus

Pathophysiol Haemost Thromb· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery : a randomised, double-blind study.
Cornelius Jungheinrich, Wilhelm Sauermann, Frank Bepperling, Norbert H Vogt

Drugs R D· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue storage of 14C-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats.
Jost Leuschner, Jens Opitz, Andreas Winkler, Roland Scharpf, Frank Bepperling

Drugs R D· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers.
Josef Waitzinger, Frank Bepperling, Günther Pabst, Jens Opitz

Drugs R D· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.
Cornelius Jungheinrich, Roland Scharpf, Manfred Wargenau, Frank Bepperling, Jean-François Baron

Anesth Analg· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis